FindTrial
Sign In

To study retina of preterm infants with retinal imaging system

Fundus fluorescein angiography to evaluate course of retinopathy of prematurity.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/020188
Enrollment
45
Registered
2019-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H351- Retinopathy of prematurity

Interventions

Intervention1: panretinal photocoagulation: 532 nm green argon panretinal photocoagulation in active disease

Sponsors

Goverment medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Inborn babies with birth weight less than or equal to 1750 grams and period of gestation less than or equal to 32 weeks or if the baby is referred to ROP screening by neonatologist will be screened and babies with ROP will be included in this study

Exclusion criteria

Exclusion criteria: Corneal opacity or hazy media precluding FFA Patients with : a) Renal failure b) Allergic reaction to dye sodium fluorescein c) Neonate on respiratory support d) Major congenital abnormality e) TORCH infections suspicion on eye examination

Design outcomes

Primary

MeasureTime frame
FFA predictors of progression of Retinopathy of prematurityTimepoint: At time of presentation—

Secondary

MeasureTime frame
vascular changes of retina on FFA after treatmentTimepoint: 6 month after treatment—

Countries

India

Contacts

Public ContactDr Amandeep Hans

Goverment Medical College and Hospital Chandigarh

subina_navya@yahoo.com9646121587

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026